CLARITY PHARMA ORDINARY (CU6) Short Interest
CLARITY PHARMA ORDINARY (ASX:CU6) had 8.26% of shares reported as short positions as of 16 May 2026, representing 30,749,780 shares. CLARITY PHARMA ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 8.26%
- Reported positions
- 30,749,780
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CU6
Clarity Pharmaceuticals
Clarity Pharmaceuticals is a clinical-stage company specializing in radiopharmaceuticals, focusing on theranostic products that combine therapy and imaging. Utilizing its proprietary SAR Technology, Clarity aims to improve cancer treatment outcomes with its Targeted Copper Theranostic platform. The company is positioned as a leader in next-generation radiopharmaceuticals, offering products that pr...